I envision AltMed as the premiere American company that brings mainstream, complementary, alternative, and integrative medicine together and places it right at the tip of the physician's pen.
Sarasota, FL (PRWEB) September 09, 2014
AltMed, a fully integrated Florida company bringing pharmaceutical industry precision to the development and production of medical cannabis is building its scientific and medical capabilities with the appointment of Dr. Valerie Riddle, MS, FACP as Chief Medical Officer and Dr. Matthew Nessetti, Ph.D, MD, JD (Candidate) as Florida Medical Director.
AltMed is led by former pharmaceutical senior executives, David Wright and Michael Smullen, who have combined their pharma experience to launch Florida’s leading integrated medical cannabis firm. The two executives share a passion for rigorous quality assurance and the scientific research required to deliver advanced high-quality treatments. Building a strong scientific and medical research team is a top priority, to drive the firm’s commitment to pharmaceutical-quality medical cannabis.
Dr. Nessetti is a Board Certified Family Physician and a Board Certified Medical Psychologist and Psychopharmacologist. He has served as a medical director for healthcare organizations for more than 20 years, and is an avid proponent of integrated health, wellness and prevention. Dr. Nessetti currently serves as medical director of the All Care Medical Center with ancillary locations in Lakewood Ranch, Venice, and throughout Sarasota and Manatee counties.
Dr. Nessetti will be responsible for ensuring quality control for all processes associated with growing, processing and dispensing low THC Medical Cannabis as required under the Compassionate Medical Cannabis Act of 2014.
"I envision AltMed as the premiere American company that brings mainstream, complementary, alternative, and integrative medicine together and places it right at the tip of the physician's pen," says Dr. Nessetti.
Dr. Riddle, received her MD from the University of South Florida and is board certified in both Internal Medicine and Infectious Diseases. She brings a wealth of medical and biotech experience in the pharmaceutical environment to AltMed. Dr. Riddle is committed to advancing leading edge knowledge about medically significant molecules produced in cannabis.
"Research and recent discoveries promise an important future for cannabinoids as targeted agents to control inflammation and pain, control symptoms associated with diseases like cancer, and provide relief from intractable seizures and spasticity associated with multiple sclerosis," says Dr. Riddle. "Dr. Nessitti and I are very excited about the potential relief AltMed-developed treatments will provide to patients in Florida."
"Our primary goal is to deliver safe, effective and consistent cannabis-based therapy options to Floridians who can benefit from these treatments," says David Wright CEO of AltMed. "Medical research and science are key to our success and we know Dr. Riddle and Dr. Nessetti will excel in their new roles."
AltMed LLC is a fully integrated, science-based Florida company bringing compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabis. Established in early 2014 by a consortium of Sarasota residents, AltMed's Executive Chairman and its CEO are both former senior pharmaceutical executives. AltMed is participating in a competitive licensure process with the objective of becoming one of five Florida licensees selected to grow and dispense medical cannabis under the Compassionate Medical Cannabis Act of 2014. For more information please visit AltMed.co.